The role of angiogenic cytokines in cardiovascular disease

Clinical Immunology and Immunopathology

Volumn 80, Issue 3 II, 1996, Pages

  Isner, Jeffrey M ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; ENDOTHELIAL CELL GROWTH FACTOR;

ANIMAL MODEL; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; EXPERIMENTAL MEDICINE; NONHUMAN; PERFUSION; PRIORITY JOURNAL; RABBIT;

EID: 0029822158     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0145     Document Type: Conference Paper

References (87)

1. Folkman, J., Tumor angiogenesis: Therapeutic implications. N. Engl. J. Med. 285, 1182-1186, 1971.
2. Shing, Y., Folkman, J., Sullivan, J., Butterfield, R., Murray, J., and Klagsbrun, M., Heparin-affinity purification of a tumor-derived capillary endothelial cell growth factor. Science 223, 1296-1299, 1984.
3. Folkman, J., and Shing, Y., Angiogenesis. J. Biol. Chem. 267, 10931-10934, 1992.
4. Höckel, M., Schlenger, K., Doctrow, S., Kissel, T., and Vaupel, P., Therapeutic angiogenesis. Arch. Surg. 128, 423-429, 1993.
5. Baffour, R., Berman, J., Garb, J. L., Rhee, S. W., Kaufman, J., and Friedmann, P., Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: Dose-response effect of basic fibroblast growth factor. J. Vasc. Surg. 16, 181-191, 1992.
6. Pu, L. Q., Sniderman, A. D., Brassard, R., Lachapelle, K. J., Graham, A. M., Lisbona, R., and Symes, J. F., Enhanced revascularization of the ischemic limb by means of angiogenic therapy. Circulation 88, 208-215, 1993.
7. Yanagisawa-Miwa, A., Uchida, Y., Nakamura, F., Tomaru, T., Kido, H., Kamijo, T., Sugimoto, T., Kaji, K., Utsuyama, M., Kurashima, C., and Ito, H., Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 257, 1401-1403, 1992.
8. Ferrara, N., and Henzel, W. J., Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161, 851-855, 1989.
9. Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J., and Connolly, D. T., Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246, 1309-1342, 1989.
10. Connolly, D. R., Olander, J. V., Heuvelman, D., Nelson, R., Monsell, R., Siegel, N., Haymore, B. L., Leimgruber, R., and Feder, J., Human vascular permeability factor: Isolation from U937 cells. J. Biol. Chem. 264, 20017-20024, 1989.
11. Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V., and Ferrara, N., Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309, 1989.
12. deVries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N., and Williams, L. T., The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255, 989-991, 1992.
13. Millauer, B., Wizigmann-Voos, S., Schnurch, H., Martinez, R., Moller, N. P. H., Risau, W., and Ulrich, A., High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72, 835-846, 1993.
14. Terman, B. I., Dougher-Vermazen, M., Carrion, M. E., Dimitrov, D., Armellino, D. C., Gospodarowicz, D., and Bohlen, P., Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem. Biophys. Res. Commun. 187, 1579-1586, 1992.
15. Klagsbrun, M., and D'Amore, P. A., Regulators of angiogenesis. Annu. Rev. Physiol. 53, 217-239, 1991.
16. Reidy, M. A., Clowes, A. W., and Schwartz, S. M., Endothelial regeneration V. Inhibition of endothelial regrowth in arteries of rat and rabbit. Lab. Invest. 49, 569-575, 1983.
17. Conn, G., Soderman, D., Schaeffer, M-T., Wile, M., Hatcher, V. B., and Thomas, K. A., Purification of glycoprotein vascular endothelial cell mitogen from a rat glioma cell line. Proc. Natl. Acad. Sci. USA 87, 1323-1327, 1990.
18. Shen, H., Clauss, M., Ryan, J., Schmidt, A-M., Tijburg, P., Borden, L., Connolly, D., Stern, D., and Kao, J., Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood 81, 2767-2773, 1993.
19. Clauss, M., Gerlach, M., Gerlach, H., Brett, J., Wang, F., Familletti, P. C., Dan, Y-C. E., Olander, J. V., Connolly, D. T., and Stern, D., Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J. Exp. Med. 172, 1535-1545, 1990.
20. Levy, A. P., Tamargo, R., Brem, H., and Nathans, D., An endothelial cell growth factor from the mouse neuroblastoma cell line NB41. Growth Factors 2, 9-19, 1989.
21. Connolly, D. T., Hewelman, D. M., Nelson, R., Olander, J. V., Eppley, B. L., Delfino, J. J., Siegel, R. N., Leimgruber, R. S., and Feder, J., Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest. 84, 1470-1478, 1989.
22. Takeshita, S., Zheng, L. P., Brogi, E., Kearney, M., Pu, L. K., Bunting, S., Ferrara, N., Symes, J. F., and Isner, J. M., Therapeutic angiogenesis: A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J. Clin. Invest. 93, 662-670, 1994.
23. Takeshita, S., Pu, L-Q., Zheng, L., Ferrara, N., Stein, L. A., Sniderman, A. D., Isner, J. M., and Symes, J. F., Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation 90[Part 2], II-228-II-234, 1994.
24. Bauters, C., Asahara, T., Zheng, L. P., Takeshita, S., Bunting, S., Ferrara, N., Symes, J. F., and Isner, J. M., Site-specific therapeutic angiogenesis following systemic administration of vascular endothelial growth factor. J. Vasc. Surg. 21, 314-325, 1995.
25. Bauters, C., Asahara, T., Zheng, L. P., Takeshita, S., Bunting, S., Ferrara, N., Symes, J. F., and Isner, J. M., Physiologic assessment of augmented vascularity induced by VEGF in rabbit ischemic hindlimb. Am. J. Physiol. 36, H1263-H1271, 1994.
26. Sellke, F. W., Quillen, J. E., Brooks, L. A., and Harrison, D. G., Endothelial modulation of the coronary vasculature in vessels perfused via mature collaterals. Circulation 81, 1938-1947, 1990.
27. Sellke, F. W., Harada, K., Wang, S. Y., Friedman, M., Simons, M., Edelman, E. R., and Grossman, W., Basic-fibroblast growth factor preserves endothelial function in the microcirculation perfused by collaterals. Abstracts of the Scientific Conference on the Molecular Cellular Biology of the Vascular Wall, Boston, MA, October 15-17, 1993, Vol. 49(Abstract), 1993.
28. Bauters, C., Asahara, T., Zheng, L. P., Takeshita, S., Bunting, S., Ferrara, N., Symes, J. F., and Isner, J. M., Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb following administration of vascular endothelial growth factor. Circulation 91, 2802-2809, 1995.
29. Losordo, D. W., Pickering, J. G., Takeshita, S., Leclerc, G., Gal, D., Weir, L., Kearney, M., Jekanowski, J., and Isner, J. M., Use of the rabbit ear artery to serially assess foreign protein secretion after site-specific arterial gene transfer in vivo: Evidence that anatomic identification of successful gene transfer may underestimate the potential magnitude of transgene expression. Circulation 89, 785-792, 1994.
30. Riessen, R., Rahimizadeh, H., Blessing, E., Takeshita, S., Barry, J. J., and Isner, J. M., Arterial gene transfer using pure DNA applied directly to a hydrogel-coated angioplasty balloon. Hum. Gene Ther. 4, 749-758, 1993.
31. Takeshita, S., Weir, L., Zheng, L. P., Chen, D., Riessen, R., Bauters, C., Symes, J. F., Ferrara, N., and Isner, J. M., Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia. Biochem. Biophys. Res. Commun., in press.
32. Ferrara, N., Houck, K. A., Jakeman, L. B., Winer, J., and Leung, D. W., The vascular endothelial growth factor family of polypeptides. J. Cell. Biochem. 47, 211-218, 1991.
33. D'Amore, P. A., and Thompson, R. W., Mechanisms of angiogenesis. Annu. Rev. Physiol. 49, 453-464, 1987.
34. Senger, D. R., Perruzzi, C. A., Feder, J., and Dvorak, H. F., A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res. 46, 5629-5632, 1986.
35. Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., and Dvorak, H. F., Tumor cells secrete a vascular perme ability factor that promotes accumulation of ascites fluid. Science 219, 983-985, 1983.
36. Dvorak, H. F., Sioussat, T. M., Brown, L. F., Berse, B., Nagy, J. A., Sotrel, A., Manseau, E. J., Van De Water, L., and Senger, D. R., Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: Concentration in tumor blood vessels. J. Exp. Med. 174, 1275-1278, 1991.
37. Schaper, W., Coronary collateral development: Concepts and hypothesis. In "Collateral Circulation: Heart, Brain, Kidney, Limbs" (W. Schaper and J. Schaper, Eds.), pp. 41-64, Kluwer Academic, Boston, MA, 1993.
38. Sholley, M. M., Ferguson, G. P., Seibel, H. R., Montour, J. L., and Wilson, J. D., Mechanisms of neovascularization: Vascular sprouting can occur without proliferation of endothelial cells. Lab. Invest. 51, 624-634, 1984.
39. Nicosia, R. F., Bonanno, E., and Smith, M., Fibronectin promotes the elongation of microvessels during angiogenesis in vitro. J. Cell. Physiol. 154, 654-661, 1993.
40. Schaper, J., and Weibrauch, D., Collateral vessel development in the porcine and canine heart. In "Collateral Circulation: Heart, Brain, Kidney, Limbs" (W. Schaper and J. Schaper, Eds.), pp. 65-102, Kluwer Academic, Boston, MA, 1993.
41. Schaper, W., de Brabander, M., and Lewi, P., DNA synthesis and mitoses in coronary collateral vessels of the dog. Circ. Res. 28, 671-679, 1971.
42. Pasyk, S., Schaper, W., Schaper, J., Pasyk, K., Miskiewicz, G., and Steinseifer, B., DNA synthesis in coronary collaterals after coronary artery occlusion in conscious dog. Am. J. Physiol. 242, H1031-H1037, 1982.
43. Cowan, D. F., Hollenberg, N. K., Connelly, C. M., Williams, D. H., and Abrams, H. L., Increased collateral arterial and venous endothelial cell turnover after renal artery stenosis in the dog. Invest. Radiol. 13, 143-149, 1978.
44. Ilich, N., Hollenberg, N. K., Williams, D. H., and Abrams, H., Time course of increased collateral arterial and venous endothelial cell turnover after renal artery stenosis in rats. Circ. Res. 45, 579-582, 1979.
45. White, F. C., Carroll, S. M., Magnet, A., and Bloor, C. M., Coronary collateral development in swine after coronary artery occlusion. Circ. Res. 71, 1490-1500, 1992.
46. Schaper, W., Schaper, J., Xhonneux, R., and Vandesteene, R., The morphology of intercoronary anastomoses in chronic coronary artery occlusion. Cardiovasc. Res. 3, 315-323, 1969.
47. Graham, A. M., Baffour, R., Burdon, T., DeVarennes, B., Ricci, M. A., Common, A., Lisbona, R., Sniderman, A. D., and Symes, J. F., A demonstration of vascular proliferation in response to arteriovenous reversal in the ischemic canine hind limb. J. Surg. Res. 47, 341-347, 1989.
48. Symes, J. F., Graham, A. M., Stein, L., and Sniderman, A. D., Salvage of a severely ischemic limb by arteriovenous revascularization: A case report. Can. J. Surg. 27, 274-276, 1984.
49. Unger, E. F., Banai, S., Shou, M., Lazarous, D. F., Jaklitsch, M. T., Scheinowitz, M., Klingbeil, C., and Epstein, S. E., Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am. J. Physiol. 266, H1588-H1595, 1994.
50. Takeshita, S., Kearney, M., Loushin, C., Brogi, E., Zheng, L. P., Horowitz, J., Ferrara, N., Symes, J. F., and Isner, J. M., In vivo evidence that vascular endothelial growth factor stimulates collateral formation by inducing arterial cell proliferation in a rabbit ischemic hindlimb. J. Am. Coll. Cardiol. 23(Abstract), 294A, 1994.
51. Dvorak, H. F., Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315, 1650-1659, 1986.
52. Herbert, J. M., Lamarche, I., Prabonnaud, V., Dol, F., and Gauthier, T., Tissue-type plasminogen activator is a potent mitogen for human aortic smooth muscle cells. J. Biol. Chem. 269, 3076-3080, 1994.
53. Pepper, M. S., Ferrara, N., Orci, L., and Montesano, R., Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor type 1 in microvascular endothelial cells. Biochem. Biophys. Res. Commun. 189, 824-831, 1994.
54. Ross, R., Glomset, B., Kariya, B., and Harker, L., A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc. Natl. Acad. Sci. USA 71, 1207-1210, 1974.
55. Collins, T., Ginsburg, D., Boss, J. M., Orkin, S. H., and Pober, J. S., Cultured human endothelial cells express platelet-derived growth factor B chain: cDNA cloning and structural analysis. Nature 316, 748-750, 1985.
56. Collins, T., Pober, J. S., Gimbrone, M. A., Jr., Betsholtz, C., Westermark, B., and Heldin, C-H., Cultured human endothelial cells express platelet-derived factor A chain. Am. J. Pathol. 126, 7-12, 1987.
57. Zerwes, H-G., and Risau, W., Polarized secretion of a platelet-derived growth factor-like chemotactic factor by endothelial cells in vitro. J. Cell Biol. 105, 2037-2041, 1987.
58. Gay, C. G., and Winkles, J. A., Heparin-binding growth factor-1 stimulation of human endothelial cells induces platelet-derived growth factor A-chain gene expression. J. Biol. Chem. 265, 3284-3292, 1990.
59. Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., Falanga, V., Kehrl, J. H., and Fauci, A. S., Transforming growth factor type-beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA 83, 4167-4171, 1986.
60. Risau, W., Drexler, H., Mironov, V., Smits, A., Siegbahn, A., Funa, K., and Heldin, C-H., Platelet-derived growth factor is angiogenic in vivo. Growth Factors 7, 261-266, 1992.
61. Lindner, V., Lappi, D. A., Baird, R. A., Majack, R. A., and Reidy, M. A., Role of basic fibroblast growth factor in vascular lesion formation. Circ. Res. 68, 106-113, 1991.
62. Lindner, V., and Reidy, M. A., Expression of basic fibroblast growth factor and its receptor by smooth muscle cells and endothelium in injured rat arteries. Circ. Res. 73, 589-595, 1993.
63. Beitz, J. G., Kim, I. S., Calabresi, P., and Frackelton, A. R., Human microvascular endothelial cells express receptors for platelet-derived growth factor. Proc. Natl. Acad. Sci. USA 88, 2021-2025, 1991.
64. Smits, A., Hermansson, M., Nister, M., Karnushina, I., Heldin, C-H., and Oberg, K., Rat brain capillary endothelial cells express functional PDGF B-type receptors. Growth Factors 2, 1-8, 1989.
65. Bar, R. S., Boes, M., Booth, B. A., Dake, B. L., Henley, S., and Hart, M. N., The effects of platelet-derived growth factor in cultured microvessel endothelial cells. Endocrinology 124, 2021-2025, 1989.
66. D'Amore, P., and Smith, S. R., Growth factor effects on cells of the vascular wall: A survey. Growth Factors 8, 61-75, 1993.
67. Pierce, G. F., Tarpley, J. E., Yanagihara, D., Mustoe, T. E., Fox, G. M., and Thomason, A., Platelet derived growth factor (BB homodimer), transforming growth factor-beta-1, and basic fibroblast growth factor in dermal wound healing. Am. J. Pathol. 140, 1375-1388, 1992.
68. Sims, D. E., The pericyte - A review. Tissue Cell 18, 153-174, 1986.
69. Sundberg, C., Ljungstrom, M., Lindmark, G., Gerdin, B., and Rubin, K., Microvascular pericytes express platelet-derived growth factor-b receptors in human healing wounds and colorectal adenocarcinoma. Am. J. Pathol. 143, 1377-1388, 1993.
70. Sato, N., Beitz, J. G., Kato, J., Yamamoto, M., Clark, J. W., Calabresi, P., and Frackelton, R. A., Jr., Platelet-derived growth factor indirectly stimulates angiogenesis in vitro. Am. J. Pathol. 142, 1119-1139, 1993.
71. Brogi, E., Wu, T., Namiki, A., and Isner, J. M., Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 90, 649-652, 1994.
72. Pepper, M. S., Vassalli, J. D., Orei, L., and Montesano, R., Biphasic effect of transforming growth factor-β1 on in vitro angiogenesis. Exp. Cell Res. 204, 356-363, 1993.
73. Chen, J. K., Hoshi, H., and McKeehan, W. L., Transforming growth factor type β specifically stimulates synthesis of proteoglycans in human adult arterial smooth muscle cells. Proc. Natl. Acad. Sci. USA 84, 5287-5291, 1987.
74. Madri, J. A., Pratt, B. M., and Tucker, A. M., Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix. J. Cell Biol. 106, 1375-1384, 1993.
75. Winkles, J. A., and Gay, C. G., Serum, phorbol ester, and polypeptide mitogens increase class 1 and 2 heparin binding (acidic and basic fibroblast growth factor) gene expression in human vascular smooth muscle cells. Cell Growth Differ. 2, 531-540, 1991.
76. Shweiki, D., Itin, A., Soffer, D., and Keshet, E., Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Science 359, 843-845, 1992.
77. Tischer, E., Mitchell, R., Hartmann, T., Silva, M., Gospodarowicz, D., Fiddes, J., and Abraham, J., The human gene for vascular endothelial growth factor: Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266, 11947-11954, 1991.
78. Wang, G. L., and Semenza, G. L., Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. Blood 268, 21513-21518, 1993.
79. Goto, F., Goto, K., Weindel, K., and Folkman, J., Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation of bovine capillary endothelial cells within collagen gels. Lab. Invest. 69, 508-517, 1993.
80. Asahara, T., Bauters, C., Pastore, C. J., Kearney, M., Rossow, S., Bunting, S., Ferrara, N., Symes, J. F., and Isner, J. M., Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimai hyperplasia in balloon-injured rat carotid artery. Circulation 91, 2793-2801, 1995.
81. Asahara, T., Bauters, C., Zheng, L. P., Takeshita, S., Bunting, S., Ferrara, N., Symes, J. F., and Isner, J. M., Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92(Suppl. II), 365-371, 1995.
82. Klagsbrun, M., and Folkman, J., Angiogenesis. In "Peptide Growth Factors and Their Receptors II" (M. B. Sporn and A. B. Roberts, Eds.), pp. 459-586, Springer-Verlag, New York, 1990.
83. Wilting, J., Christ, B., Bokdloh, M., and Weich, H. A., In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane. Cell Tissue Res. 68, 106-113, 1993.
84. Klagsbrun, M., and Baird, A., A duel receptor system is required for basic fibroblast growth factor activity. Cell 67, 229-231, 1991.
85. Park, J. E., Chen, H. H., Winer, J., Houck, K. A., and Ferrara, N., Placenta growth factor: Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J. Biol. Chem. 269, 25646-25654, 1994.
86. Isner, J. M., Walsh, K., Symes, J. F., Piezcek, A., Takeshita, S., Lowry, J., Rosenfield, K., Weir, L., Brogi, E., and Jurayj, D., Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease. Circulation 91, 2687-2692, 1995.
87. Fischer, M., Meadows, M-E., Do, T., Weise, J., Trubetskoy, V., Charette, M., and Finkelstein, S. P., Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent cerebral ischemia in rats. J. Cereb. Blood Flow Metab., in press.